Skills Shortages could Scupper Singapores Growth Prospects
As increasing numbers of pharmaceutical companies expand into Singapore, and businesses experience high levels of staff movement as a result of heightened confidence amongst jobseekers, future growth could be affected by a marked skills shortage. That’s according to the latest Global Sentiment Survey from Berkley Group, which analyses employment and market perceptions internationally.
People Crisis Looms for Pharma Companies
Recent reports from the Ministry of Trade reveal that the Singapore economy grew 5.4% in Q1 2014 which has, in turn, led to increased investment in the region and heightened confidence amongst jobseekers and employers alike. Despite this, however, Berkley’s research reveals that future growth may be halted by a lack of available talent. The report revealed that 80% of the current workforce intends to move jobs in the next year, with 60% planning to do so within 6 months. This is in keeping with recent research from Sylvia Vorhauser-Smith, Senior Vice President of Research at PageUp People, which reveals that regular job hopping is prevalent in the country’s workforce.
Robust Attraction and Retention Strategy a must for Employers
This high level of predicted movement amongst the workforce is likely to exacerbate the already present concerns surrounding talent retention and attraction in Singapore. This, coupled with increasing pressure mounted on employers to hire locals before expats, means that staffing strategies need to be far more succinct to help organisations attract and retain those professionals with the requisite skill sets to prevent a slowdown in growth. This is a sentiment mirrored in Berkley’s research which reveals that, whilst 90% of those surveyed expect a pay rise in the coming year, very few reported financial incentives as a contributing factor in moving jobs (30%). In comparison, 57% acknowledged that career progression would be the biggest driver. These results suggest there is currently a significant disconnect between staff preferences and workplace incentives.
Wendy Cheong, Practice Director at Berkley Group, comments: “The Singapore economy is currently experiencing a period of intense change as plans for economic development and growth remains a high priority for the government. However, for businesses to remain competitive, it’s vital that they have the right talent on board, an objective that has long been a challenge with high levels of staff turnover and a heavy reliance on expats in the country. As recruitment activity looks set to increase, there will need to be a change in the mindset of employers to ensure they are providing the right opportunities to attract and retain staff to prevent marked skills shortages. As financial incentives continue to drop off the radar of the workforce, perhaps career development opportunities need to be considered as part of the talent attraction strategy.”
To see the report visit www.berkley.com.sg/research-download
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance